Effect of risedronate in a minipig cartilage defect model with allograft.
D000818:Animals; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001862:Bone Resorption / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D002358:Cartilage, Articular / Q000293:injuries* / Q000473:pathology; D019902:Chondrocytes / Q000637:transplantation*; D024042:Collagen Type I / Q000032:analysis; D024043:Collagen Type II / Q000032:analysis; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D008297:Male; D000068296:Risedronic Acid; D013552:Swine; D013556:Swine, Miniature; D014184:Transplantation, Homologous / Q000009:adverse effects
D050071:Bone Density Conservation Agents; D024042:Collagen Type I; D024043:Collagen Type II; D000068296:Risedronic Acid; D012968:Etidronic Acid